Form 4 for MRNA Moderna
Accepted 2021-12-30 00:00:00 ET · period of report 2021-12-29 · accession 0001127602-21-032070 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-12-30 | 2021-12-29 | MRNA | Bancel Stephane | CEO, Dir | G - Gift | — | -4,000 | 5.79M | -0.1% | — | |
| 2021-12-30 | 2021-12-29 | MRNA | Bancel Stephane | CEO, Dir | S - Sale | $240.00 | -9,000 | 5.79M | -0.2% | -$2.16M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-12-29 | G | D | 4,000 | — | 5,788,535 | D | — | — | (F3) The reported disposition represents a bona fide charitable gift made by the reporting person. |
| 2 | Common | Common Stock | 2021-12-29 | S | D | 9,000 | $240.00 | 5,792,535 | D | — | — |